nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Teniposide—lung cancer	0.206	1	CrCtD
Etoposide—Podofilox—Teniposide—lung cancer	0.118	1	CrCrCtD
Etoposide—Topoisomerase Inhibitors—Teniposide—lung cancer	0.0838	0.33	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Topotecan—lung cancer	0.0747	0.294	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Irinotecan—lung cancer	0.0635	0.25	CiPCiCtD
Etoposide—muscle cancer—lung cancer	0.0477	0.366	CtDrD
Etoposide—testicular cancer—lung cancer	0.0447	0.343	CtDrD
Etoposide—sarcoma—lung cancer	0.038	0.292	CtDrD
Etoposide—Topoisomerase Inhibitors—Doxorubicin—lung cancer	0.0317	0.125	CiPCiCtD
Etoposide—ABCC3—lung cancer	0.0231	0.205	CbGaD
Etoposide—GSTT1—lung cancer	0.022	0.195	CbGaD
Etoposide—UGT1A1—lung cancer	0.02	0.177	CbGaD
Etoposide—GSTP1—lung cancer	0.0174	0.154	CbGaD
Etoposide—ABCG2—lung cancer	0.0112	0.0996	CbGaD
Etoposide—ABCC6—Teniposide—lung cancer	0.0109	0.0899	CbGbCtD
Etoposide—CYP2E1—lung cancer	0.00891	0.079	CbGaD
Etoposide—GSTT1—Cisplatin—lung cancer	0.0085	0.0702	CbGbCtD
Etoposide—TOP2A—Teniposide—lung cancer	0.00579	0.0478	CbGbCtD
Etoposide—PTGS2—lung cancer	0.00549	0.0487	CbGaD
Etoposide—ABCC6—Vinblastine—lung cancer	0.00533	0.044	CbGbCtD
Etoposide—GSTP1—Cisplatin—lung cancer	0.00531	0.0439	CbGbCtD
Etoposide—ABCC10—Gemcitabine—lung cancer	0.00513	0.0424	CbGbCtD
Etoposide—ABCC6—Cisplatin—lung cancer	0.00488	0.0403	CbGbCtD
Etoposide—ABCB1—lung cancer	0.00467	0.0414	CbGaD
Etoposide—ABCC10—Paclitaxel—lung cancer	0.00464	0.0383	CbGbCtD
Etoposide—ABCC10—Docetaxel—lung cancer	0.00335	0.0277	CbGbCtD
Etoposide—ABCC6—Doxorubicin—lung cancer	0.00327	0.027	CbGbCtD
Etoposide—ABCC10—Doxorubicin—lung cancer	0.0025	0.0207	CbGbCtD
Etoposide—ABCC10—Methotrexate—lung cancer	0.00242	0.02	CbGbCtD
Etoposide—ABCG2—Topotecan—lung cancer	0.00242	0.02	CbGbCtD
Etoposide—UGT1A1—Erlotinib—lung cancer	0.00238	0.0197	CbGbCtD
Etoposide—ABCC3—Cisplatin—lung cancer	0.00235	0.0194	CbGbCtD
Etoposide—ABCG2—Gefitinib—lung cancer	0.00221	0.0183	CbGbCtD
Etoposide—UGT1A1—Irinotecan—lung cancer	0.00215	0.0178	CbGbCtD
Etoposide—ABCG2—Teniposide—lung cancer	0.00215	0.0177	CbGbCtD
Etoposide—ABCC1—Paclitaxel—lung cancer	0.00179	0.0148	CbGbCtD
Etoposide—ABCC1—Irinotecan—lung cancer	0.00177	0.0146	CbGbCtD
Etoposide—TOP2A—Doxorubicin—lung cancer	0.00174	0.0144	CbGbCtD
Etoposide—ABCC3—Doxorubicin—lung cancer	0.00157	0.013	CbGbCtD
Etoposide—ABCC1—Vinblastine—lung cancer	0.00157	0.013	CbGbCtD
Etoposide—ABCC3—Methotrexate—lung cancer	0.00152	0.0126	CbGbCtD
Etoposide—ABCC2—Paclitaxel—lung cancer	0.00133	0.011	CbGbCtD
Etoposide—ABCG2—Erlotinib—lung cancer	0.00131	0.0108	CbGbCtD
Etoposide—ABCC2—Irinotecan—lung cancer	0.00131	0.0108	CbGbCtD
Etoposide—ABCC1—Docetaxel—lung cancer	0.0013	0.0107	CbGbCtD
Etoposide—CYP3A5—Gefitinib—lung cancer	0.00123	0.0101	CbGbCtD
Etoposide—ABCG2—Paclitaxel—lung cancer	0.0012	0.0099	CbGbCtD
Etoposide—CYP3A5—Teniposide—lung cancer	0.00119	0.00983	CbGbCtD
Etoposide—ABCG2—Irinotecan—lung cancer	0.00118	0.00977	CbGbCtD
Etoposide—ABCC2—Vinblastine—lung cancer	0.00116	0.00961	CbGbCtD
Etoposide—ABCC2—Cisplatin—lung cancer	0.00107	0.00881	CbGbCtD
Etoposide—PTGS2—Cisplatin—lung cancer	0.00105	0.0087	CbGbCtD
Etoposide—ABCC1—Doxorubicin—lung cancer	0.000965	0.00797	CbGbCtD
Etoposide—ABCG2—Cisplatin—lung cancer	0.000964	0.00796	CbGbCtD
Etoposide—ABCC2—Docetaxel—lung cancer	0.000959	0.00792	CbGbCtD
Etoposide—ABCC1—Methotrexate—lung cancer	0.000935	0.00773	CbGbCtD
Etoposide—ABCB1—Topotecan—lung cancer	0.000873	0.00721	CbGbCtD
Etoposide—ABCG2—Docetaxel—lung cancer	0.000867	0.00716	CbGbCtD
Etoposide—ABCB1—Gefitinib—lung cancer	0.000799	0.0066	CbGbCtD
Etoposide—CYP3A5—Crizotinib—lung cancer	0.000752	0.00621	CbGbCtD
Etoposide—CYP3A5—Erlotinib—lung cancer	0.000725	0.00599	CbGbCtD
Etoposide—ABCC2—Doxorubicin—lung cancer	0.000715	0.0059	CbGbCtD
Etoposide—CYP2C8—Erlotinib—lung cancer	0.000698	0.00576	CbGbCtD
Etoposide—ABCC2—Methotrexate—lung cancer	0.000692	0.00572	CbGbCtD
Etoposide—CYP3A5—Paclitaxel—lung cancer	0.000664	0.00549	CbGbCtD
Etoposide—Teniposide—NCOA3—lung cancer	0.00066	0.835	CrCbGaD
Etoposide—CYP3A5—Irinotecan—lung cancer	0.000655	0.00541	CbGbCtD
Etoposide—ABCG2—Doxorubicin—lung cancer	0.000646	0.00534	CbGbCtD
Etoposide—CYP2C8—Paclitaxel—lung cancer	0.000639	0.00527	CbGbCtD
Etoposide—ABCG2—Methotrexate—lung cancer	0.000626	0.00517	CbGbCtD
Etoposide—ABCB1—Vinorelbine—lung cancer	0.000615	0.00508	CbGbCtD
Etoposide—CYP1A2—Erlotinib—lung cancer	0.00054	0.00446	CbGbCtD
Etoposide—CYP3A4—Topotecan—lung cancer	0.000523	0.00432	CbGbCtD
Etoposide—ABCB1—Crizotinib—lung cancer	0.000489	0.00404	CbGbCtD
Etoposide—CYP3A5—Docetaxel—lung cancer	0.00048	0.00397	CbGbCtD
Etoposide—CYP3A4—Gefitinib—lung cancer	0.000478	0.00395	CbGbCtD
Etoposide—ABCB1—Gemcitabine—lung cancer	0.000478	0.00395	CbGbCtD
Etoposide—ABCB1—Erlotinib—lung cancer	0.000472	0.0039	CbGbCtD
Etoposide—CYP3A4—Teniposide—lung cancer	0.000464	0.00383	CbGbCtD
Etoposide—ABCB1—Paclitaxel—lung cancer	0.000432	0.00357	CbGbCtD
Etoposide—ABCB1—Irinotecan—lung cancer	0.000426	0.00352	CbGbCtD
Etoposide—ABCB1—Vinblastine—lung cancer	0.000379	0.00313	CbGbCtD
Etoposide—CYP3A4—Vinorelbine—lung cancer	0.000369	0.00304	CbGbCtD
Etoposide—ABCB1—Cisplatin—lung cancer	0.000348	0.00287	CbGbCtD
Etoposide—TOP2B—mammary gland—lung cancer	0.000316	0.0594	CbGeAlD
Etoposide—ABCB1—Docetaxel—lung cancer	0.000312	0.00258	CbGbCtD
Etoposide—CYP3A4—Crizotinib—lung cancer	0.000293	0.00242	CbGbCtD
Etoposide—GSTT1—respiratory system—lung cancer	0.000286	0.0537	CbGeAlD
Etoposide—CYP3A4—Erlotinib—lung cancer	0.000283	0.00234	CbGbCtD
Etoposide—CYP3A4—Paclitaxel—lung cancer	0.000259	0.00214	CbGbCtD
Etoposide—CYP3A4—Irinotecan—lung cancer	0.000255	0.00211	CbGbCtD
Etoposide—ABCB1—Doxorubicin—lung cancer	0.000233	0.00192	CbGbCtD
Etoposide—CYP3A4—Vinblastine—lung cancer	0.000227	0.00188	CbGbCtD
Etoposide—ABCB1—Methotrexate—lung cancer	0.000226	0.00186	CbGbCtD
Etoposide—TOP2B—respiratory system—lung cancer	0.000211	0.0396	CbGeAlD
Etoposide—CYP3A4—Docetaxel—lung cancer	0.000187	0.00155	CbGbCtD
Etoposide—TOP2B—Topotecan—Irinotecan—lung cancer	0.000174	0.27	CbGdCrCtD
Etoposide—TOP2B—bronchus—lung cancer	0.000174	0.0326	CbGeAlD
Etoposide—TOP2B—trachea—lung cancer	0.000156	0.0292	CbGeAlD
Etoposide—GSTT1—lung—lung cancer	0.000152	0.0285	CbGeAlD
Etoposide—TOP2B—cardiac atrium—lung cancer	0.000146	0.0275	CbGeAlD
Etoposide—CYP3A4—Doxorubicin—lung cancer	0.00014	0.00115	CbGbCtD
Etoposide—ABCC3—respiratory system—lung cancer	0.000133	0.0249	CbGeAlD
Etoposide—GSTP1—respiratory system—lung cancer	0.000132	0.0248	CbGeAlD
Etoposide—Teniposide—ABCG2—lung cancer	0.000131	0.166	CrCbGaD
Etoposide—TOP2A—bronchus—lung cancer	0.000128	0.0239	CbGeAlD
Etoposide—TOP2B—bone marrow—lung cancer	0.000124	0.0232	CbGeAlD
Etoposide—ABCC6—lung—lung cancer	0.000123	0.0232	CbGeAlD
Etoposide—CYP2C8—mammary gland—lung cancer	0.000119	0.0224	CbGeAlD
Etoposide—ABCC6—Podofilox—Teniposide—lung cancer	0.000117	0.182	CbGdCrCtD
Etoposide—TOP2B—lung—lung cancer	0.000112	0.021	CbGeAlD
Etoposide—GSTP1—epithelium—lung cancer	0.00011	0.0207	CbGeAlD
Etoposide—GSTP1—bronchus—lung cancer	0.000109	0.0204	CbGeAlD
Etoposide—ABCC10—bronchus—lung cancer	0.000109	0.0204	CbGeAlD
Etoposide—GSTP1—trachea—lung cancer	9.76e-05	0.0183	CbGeAlD
Etoposide—ABCC10—trachea—lung cancer	9.75e-05	0.0183	CbGeAlD
Etoposide—GSTP1—cardiac atrium—lung cancer	9.17e-05	0.0172	CbGeAlD
Etoposide—ABCC10—cardiac atrium—lung cancer	9.16e-05	0.0172	CbGeAlD
Etoposide—TOP2A—bone marrow—lung cancer	9.09e-05	0.0171	CbGeAlD
Etoposide—TOP2A—lung—lung cancer	8.23e-05	0.0154	CbGeAlD
Etoposide—GSTP1—bone marrow—lung cancer	7.74e-05	0.0145	CbGeAlD
Etoposide—ABCC10—bone marrow—lung cancer	7.74e-05	0.0145	CbGeAlD
Etoposide—ABCC1—bronchus—lung cancer	7.68e-05	0.0144	CbGeAlD
Etoposide—TOP2B—lymph node—lung cancer	7.66e-05	0.0144	CbGeAlD
Etoposide—CYP1A2—respiratory system—lung cancer	7.44e-05	0.014	CbGeAlD
Etoposide—CYP3A5—respiratory system—lung cancer	7.17e-05	0.0135	CbGeAlD
Etoposide—ABCC3—lung—lung cancer	7.04e-05	0.0132	CbGeAlD
Etoposide—GSTP1—lung—lung cancer	7.01e-05	0.0132	CbGeAlD
Etoposide—ABCC10—lung—lung cancer	7.01e-05	0.0132	CbGeAlD
Etoposide—ABCC1—trachea—lung cancer	6.9e-05	0.0129	CbGeAlD
Etoposide—CYP2E1—respiratory system—lung cancer	6.69e-05	0.0126	CbGeAlD
Etoposide—ABCC1—cardiac atrium—lung cancer	6.48e-05	0.0122	CbGeAlD
Etoposide—PTGS1—respiratory system—lung cancer	6.45e-05	0.0121	CbGeAlD
Etoposide—PTGS2—respiratory system—lung cancer	6.16e-05	0.0116	CbGeAlD
Etoposide—TOP2A—lymph node—lung cancer	5.63e-05	0.0106	CbGeAlD
Etoposide—PTGS1—epithelium—lung cancer	5.39e-05	0.0101	CbGeAlD
Etoposide—PTGS2—epithelium—lung cancer	5.15e-05	0.00966	CbGeAlD
Etoposide—PTGS2—bronchus—lung cancer	5.07e-05	0.00951	CbGeAlD
Etoposide—ABCC1—lung—lung cancer	4.96e-05	0.0093	CbGeAlD
Etoposide—ABCC3—lymph node—lung cancer	4.82e-05	0.00904	CbGeAlD
Etoposide—GSTP1—lymph node—lung cancer	4.8e-05	0.009	CbGeAlD
Etoposide—ABCC10—lymph node—lung cancer	4.79e-05	0.00899	CbGeAlD
Etoposide—PTGS1—trachea—lung cancer	4.76e-05	0.00894	CbGeAlD
Etoposide—PTGS2—trachea—lung cancer	4.55e-05	0.00854	CbGeAlD
Etoposide—ABCG2—bone marrow—lung cancer	4.53e-05	0.0085	CbGeAlD
Etoposide—PTGS1—cardiac atrium—lung cancer	4.47e-05	0.0084	CbGeAlD
Etoposide—ABCG2—lung—lung cancer	4.1e-05	0.0077	CbGeAlD
Etoposide—CYP1A2—lung—lung cancer	3.95e-05	0.00741	CbGeAlD
Etoposide—TOP2A—Docetaxel—Paclitaxel—lung cancer	3.94e-05	0.0612	CbGdCrCtD
Etoposide—ABCC2—lymph node—lung cancer	3.85e-05	0.00722	CbGeAlD
Etoposide—ABCB1—respiratory system—lung cancer	3.81e-05	0.00715	CbGeAlD
Etoposide—CYP3A5—lung—lung cancer	3.81e-05	0.00715	CbGeAlD
Etoposide—PTGS2—bone marrow—lung cancer	3.61e-05	0.00678	CbGeAlD
Etoposide—CYP2E1—lung—lung cancer	3.55e-05	0.00667	CbGeAlD
Etoposide—PTGS1—lung—lung cancer	3.42e-05	0.00642	CbGeAlD
Etoposide—ABCC1—lymph node—lung cancer	3.39e-05	0.00636	CbGeAlD
Etoposide—TOP2A—Irinotecan—Topotecan—lung cancer	3.38e-05	0.0524	CbGdCrCtD
Etoposide—PTGS2—lung—lung cancer	3.27e-05	0.00614	CbGeAlD
Etoposide—ABCB1—epithelium—lung cancer	3.18e-05	0.00598	CbGeAlD
Etoposide—TOP2A—Erlotinib—Gefitinib—lung cancer	2.94e-05	0.0457	CbGdCrCtD
Etoposide—ABCB1—trachea—lung cancer	2.82e-05	0.00528	CbGeAlD
Etoposide—ABCG2—lymph node—lung cancer	2.81e-05	0.00527	CbGeAlD
Etoposide—TOP2A—Topotecan—Irinotecan—lung cancer	2.8e-05	0.0435	CbGdCrCtD
Etoposide—TOP2A—Vindesine—Vinorelbine—lung cancer	2.51e-05	0.0389	CbGdCrCtD
Etoposide—PTGS1—lymph node—lung cancer	2.34e-05	0.00439	CbGeAlD
Etoposide—PTGS2—lymph node—lung cancer	2.24e-05	0.0042	CbGeAlD
Etoposide—ABCB1—bone marrow—lung cancer	2.23e-05	0.00419	CbGeAlD
Etoposide—TOP2A—Podofilox—Teniposide—lung cancer	2.13e-05	0.033	CbGdCrCtD
Etoposide—ABCB1—lung—lung cancer	2.02e-05	0.0038	CbGeAlD
Etoposide—TOP2A—Vindesine—Vinblastine—lung cancer	2e-05	0.0311	CbGdCrCtD
Etoposide—TOP2A—Methotrexate—Pemetrexed—lung cancer	2e-05	0.0311	CbGdCrCtD
Etoposide—TOP2A—Paclitaxel—Docetaxel—lung cancer	1.97e-05	0.0306	CbGdCrCtD
Etoposide—TOP2A—Afatinib—Gefitinib—lung cancer	1.93e-05	0.0299	CbGdCrCtD
Etoposide—TOP2A—Gefitinib—Erlotinib—lung cancer	1.89e-05	0.0293	CbGdCrCtD
Etoposide—ABCB1—lymph node—lung cancer	1.38e-05	0.0026	CbGeAlD
Etoposide—TOP2A—Vincristine—Vinorelbine—lung cancer	1.35e-05	0.021	CbGdCrCtD
Etoposide—TOP2A—Vinorelbine—Vinblastine—lung cancer	1.27e-05	0.0196	CbGdCrCtD
Etoposide—TOP2A—Vinblastine—Vinorelbine—lung cancer	1.09e-05	0.0169	CbGdCrCtD
Etoposide—TOP2A—Vincristine—Vinblastine—lung cancer	1.08e-05	0.0168	CbGdCrCtD
Etoposide—Feeling abnormal—Irinotecan—lung cancer	9.69e-06	0.0003	CcSEcCtD
Etoposide—Confusional state—Paclitaxel—lung cancer	9.67e-06	0.0003	CcSEcCtD
Etoposide—Back pain—Docetaxel—lung cancer	9.64e-06	0.000299	CcSEcCtD
Etoposide—Neutropenia—Methotrexate—lung cancer	9.64e-06	0.000299	CcSEcCtD
Etoposide—Gastrointestinal pain—Irinotecan—lung cancer	9.62e-06	0.000298	CcSEcCtD
Etoposide—Anaphylactic shock—Paclitaxel—lung cancer	9.59e-06	0.000297	CcSEcCtD
Etoposide—Paraesthesia—Cisplatin—lung cancer	9.59e-06	0.000297	CcSEcCtD
Etoposide—Muscle spasms—Docetaxel—lung cancer	9.58e-06	0.000297	CcSEcCtD
Etoposide—Infection—Paclitaxel—lung cancer	9.53e-06	0.000295	CcSEcCtD
Etoposide—Dyspnoea—Cisplatin—lung cancer	9.52e-06	0.000295	CcSEcCtD
Etoposide—Feeling abnormal—Gemcitabine—lung cancer	9.44e-06	0.000293	CcSEcCtD
Etoposide—Dizziness—Vinorelbine—lung cancer	9.43e-06	0.000292	CcSEcCtD
Etoposide—Thrombocytopenia—Paclitaxel—lung cancer	9.39e-06	0.000291	CcSEcCtD
Etoposide—Tachycardia—Paclitaxel—lung cancer	9.36e-06	0.00029	CcSEcCtD
Etoposide—Skin disorder—Paclitaxel—lung cancer	9.32e-06	0.000289	CcSEcCtD
Etoposide—Abdominal pain—Irinotecan—lung cancer	9.3e-06	0.000288	CcSEcCtD
Etoposide—Body temperature increased—Irinotecan—lung cancer	9.3e-06	0.000288	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Doxorubicin—lung cancer	9.3e-06	0.000288	CcSEcCtD
Etoposide—Decreased appetite—Cisplatin—lung cancer	9.29e-06	0.000288	CcSEcCtD
Etoposide—Hyperhidrosis—Paclitaxel—lung cancer	9.28e-06	0.000287	CcSEcCtD
Etoposide—Pneumonia—Methotrexate—lung cancer	9.24e-06	0.000286	CcSEcCtD
Etoposide—Gastrointestinal disorder—Cisplatin—lung cancer	9.22e-06	0.000286	CcSEcCtD
Etoposide—Anaemia—Docetaxel—lung cancer	9.21e-06	0.000285	CcSEcCtD
Etoposide—Infestation NOS—Methotrexate—lung cancer	9.19e-06	0.000285	CcSEcCtD
Etoposide—Infestation—Methotrexate—lung cancer	9.19e-06	0.000285	CcSEcCtD
Etoposide—Anorexia—Paclitaxel—lung cancer	9.15e-06	0.000283	CcSEcCtD
Etoposide—Pain—Cisplatin—lung cancer	9.13e-06	0.000283	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Methotrexate—lung cancer	9.11e-06	0.000282	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Doxorubicin—lung cancer	9.11e-06	0.000282	CcSEcCtD
Etoposide—Vomiting—Vinorelbine—lung cancer	9.07e-06	0.000281	CcSEcCtD
Etoposide—Body temperature increased—Gemcitabine—lung cancer	9.06e-06	0.000281	CcSEcCtD
Etoposide—Renal failure—Methotrexate—lung cancer	9.03e-06	0.00028	CcSEcCtD
Etoposide—Rash—Vinorelbine—lung cancer	8.99e-06	0.000279	CcSEcCtD
Etoposide—Dermatitis—Vinorelbine—lung cancer	8.99e-06	0.000278	CcSEcCtD
Etoposide—Hypotension—Paclitaxel—lung cancer	8.97e-06	0.000278	CcSEcCtD
Etoposide—Stomatitis—Methotrexate—lung cancer	8.96e-06	0.000278	CcSEcCtD
Etoposide—Headache—Vinorelbine—lung cancer	8.94e-06	0.000277	CcSEcCtD
Etoposide—Dysphagia—Doxorubicin—lung cancer	8.93e-06	0.000277	CcSEcCtD
Etoposide—Leukopenia—Docetaxel—lung cancer	8.92e-06	0.000276	CcSEcCtD
Etoposide—Feeling abnormal—Cisplatin—lung cancer	8.8e-06	0.000273	CcSEcCtD
Etoposide—Loss of consciousness—Docetaxel—lung cancer	8.76e-06	0.000271	CcSEcCtD
Etoposide—Cough—Docetaxel—lung cancer	8.7e-06	0.000269	CcSEcCtD
Etoposide—Hepatobiliary disease—Methotrexate—lung cancer	8.69e-06	0.000269	CcSEcCtD
Etoposide—Hypersensitivity—Irinotecan—lung cancer	8.67e-06	0.000269	CcSEcCtD
Etoposide—Convulsion—Docetaxel—lung cancer	8.63e-06	0.000268	CcSEcCtD
Etoposide—Paraesthesia—Paclitaxel—lung cancer	8.62e-06	0.000267	CcSEcCtD
Etoposide—Hypertension—Docetaxel—lung cancer	8.6e-06	0.000267	CcSEcCtD
Etoposide—Agranulocytosis—Methotrexate—lung cancer	8.58e-06	0.000266	CcSEcCtD
Etoposide—Dyspnoea—Paclitaxel—lung cancer	8.55e-06	0.000265	CcSEcCtD
Etoposide—Somnolence—Paclitaxel—lung cancer	8.53e-06	0.000264	CcSEcCtD
Etoposide—Chest pain—Docetaxel—lung cancer	8.48e-06	0.000263	CcSEcCtD
Etoposide—Pancytopenia—Doxorubicin—lung cancer	8.48e-06	0.000263	CcSEcCtD
Etoposide—Nausea—Vinorelbine—lung cancer	8.47e-06	0.000263	CcSEcCtD
Etoposide—Body temperature increased—Cisplatin—lung cancer	8.44e-06	0.000262	CcSEcCtD
Etoposide—Asthenia—Irinotecan—lung cancer	8.44e-06	0.000262	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	8.43e-06	0.000261	CcSEcCtD
Etoposide—Neutropenia—Doxorubicin—lung cancer	8.35e-06	0.000259	CcSEcCtD
Etoposide—Decreased appetite—Paclitaxel—lung cancer	8.34e-06	0.000258	CcSEcCtD
Etoposide—Gastrointestinal disorder—Paclitaxel—lung cancer	8.28e-06	0.000257	CcSEcCtD
Etoposide—Fatigue—Paclitaxel—lung cancer	8.27e-06	0.000256	CcSEcCtD
Etoposide—Asthenia—Gemcitabine—lung cancer	8.22e-06	0.000255	CcSEcCtD
Etoposide—Constipation—Paclitaxel—lung cancer	8.2e-06	0.000254	CcSEcCtD
Etoposide—Pain—Paclitaxel—lung cancer	8.2e-06	0.000254	CcSEcCtD
Etoposide—Confusional state—Docetaxel—lung cancer	8.2e-06	0.000254	CcSEcCtD
Etoposide—Urinary tract disorder—Methotrexate—lung cancer	8.15e-06	0.000253	CcSEcCtD
Etoposide—Anaphylactic shock—Docetaxel—lung cancer	8.13e-06	0.000252	CcSEcCtD
Etoposide—Pruritus—Gemcitabine—lung cancer	8.11e-06	0.000251	CcSEcCtD
Etoposide—Urethral disorder—Methotrexate—lung cancer	8.09e-06	0.000251	CcSEcCtD
Etoposide—Infection—Docetaxel—lung cancer	8.08e-06	0.00025	CcSEcCtD
Etoposide—Diarrhoea—Irinotecan—lung cancer	8.05e-06	0.000249	CcSEcCtD
Etoposide—Pneumonia—Doxorubicin—lung cancer	8e-06	0.000248	CcSEcCtD
Etoposide—Thrombocytopenia—Docetaxel—lung cancer	7.96e-06	0.000247	CcSEcCtD
Etoposide—Infestation NOS—Doxorubicin—lung cancer	7.96e-06	0.000247	CcSEcCtD
Etoposide—Infestation—Doxorubicin—lung cancer	7.96e-06	0.000247	CcSEcCtD
Etoposide—Tachycardia—Docetaxel—lung cancer	7.94e-06	0.000246	CcSEcCtD
Etoposide—Feeling abnormal—Paclitaxel—lung cancer	7.91e-06	0.000245	CcSEcCtD
Etoposide—Skin disorder—Docetaxel—lung cancer	7.9e-06	0.000245	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Doxorubicin—lung cancer	7.89e-06	0.000245	CcSEcCtD
Etoposide—Hypersensitivity—Cisplatin—lung cancer	7.87e-06	0.000244	CcSEcCtD
Etoposide—Gastrointestinal pain—Paclitaxel—lung cancer	7.85e-06	0.000243	CcSEcCtD
Etoposide—Diarrhoea—Gemcitabine—lung cancer	7.84e-06	0.000243	CcSEcCtD
Etoposide—Renal failure—Doxorubicin—lung cancer	7.82e-06	0.000242	CcSEcCtD
Etoposide—Erythema multiforme—Methotrexate—lung cancer	7.8e-06	0.000242	CcSEcCtD
Etoposide—Neuropathy peripheral—Doxorubicin—lung cancer	7.8e-06	0.000242	CcSEcCtD
Etoposide—Dizziness—Irinotecan—lung cancer	7.78e-06	0.000241	CcSEcCtD
Etoposide—Stomatitis—Doxorubicin—lung cancer	7.76e-06	0.00024	CcSEcCtD
Etoposide—Jaundice—Doxorubicin—lung cancer	7.76e-06	0.00024	CcSEcCtD
Etoposide—Anorexia—Docetaxel—lung cancer	7.75e-06	0.00024	CcSEcCtD
Etoposide—Eye disorder—Methotrexate—lung cancer	7.71e-06	0.000239	CcSEcCtD
Etoposide—Asthenia—Cisplatin—lung cancer	7.66e-06	0.000238	CcSEcCtD
Etoposide—Cardiac disorder—Methotrexate—lung cancer	7.66e-06	0.000237	CcSEcCtD
Etoposide—Urticaria—Paclitaxel—lung cancer	7.62e-06	0.000236	CcSEcCtD
Etoposide—Hypotension—Docetaxel—lung cancer	7.6e-06	0.000236	CcSEcCtD
Etoposide—Abdominal pain—Paclitaxel—lung cancer	7.58e-06	0.000235	CcSEcCtD
Etoposide—Body temperature increased—Paclitaxel—lung cancer	7.58e-06	0.000235	CcSEcCtD
Etoposide—Hepatobiliary disease—Doxorubicin—lung cancer	7.53e-06	0.000233	CcSEcCtD
Etoposide—Angiopathy—Methotrexate—lung cancer	7.49e-06	0.000232	CcSEcCtD
Etoposide—Vomiting—Irinotecan—lung cancer	7.48e-06	0.000232	CcSEcCtD
Etoposide—Immune system disorder—Methotrexate—lung cancer	7.45e-06	0.000231	CcSEcCtD
Etoposide—Mediastinal disorder—Methotrexate—lung cancer	7.44e-06	0.00023	CcSEcCtD
Etoposide—Agranulocytosis—Doxorubicin—lung cancer	7.43e-06	0.00023	CcSEcCtD
Etoposide—Rash—Irinotecan—lung cancer	7.42e-06	0.00023	CcSEcCtD
Etoposide—Dermatitis—Irinotecan—lung cancer	7.41e-06	0.00023	CcSEcCtD
Etoposide—Chills—Methotrexate—lung cancer	7.4e-06	0.000229	CcSEcCtD
Etoposide—Headache—Irinotecan—lung cancer	7.37e-06	0.000228	CcSEcCtD
Etoposide—Diarrhoea—Cisplatin—lung cancer	7.31e-06	0.000227	CcSEcCtD
Etoposide—Paraesthesia—Docetaxel—lung cancer	7.3e-06	0.000226	CcSEcCtD
Etoposide—Alopecia—Methotrexate—lung cancer	7.29e-06	0.000226	CcSEcCtD
Etoposide—Vomiting—Gemcitabine—lung cancer	7.29e-06	0.000226	CcSEcCtD
Etoposide—Dyspnoea—Docetaxel—lung cancer	7.25e-06	0.000225	CcSEcCtD
Etoposide—Somnolence—Docetaxel—lung cancer	7.23e-06	0.000224	CcSEcCtD
Etoposide—Rash—Gemcitabine—lung cancer	7.23e-06	0.000224	CcSEcCtD
Etoposide—Dermatitis—Gemcitabine—lung cancer	7.22e-06	0.000224	CcSEcCtD
Etoposide—Headache—Gemcitabine—lung cancer	7.18e-06	0.000223	CcSEcCtD
Etoposide—TOP2A—Cytarabine—Gemcitabine—lung cancer	7.11e-06	0.011	CbGdCrCtD
Etoposide—Hypoaesthesia—Doxorubicin—lung cancer	7.11e-06	0.00022	CcSEcCtD
Etoposide—Decreased appetite—Docetaxel—lung cancer	7.07e-06	0.000219	CcSEcCtD
Etoposide—Hypersensitivity—Paclitaxel—lung cancer	7.07e-06	0.000219	CcSEcCtD
Etoposide—Urinary tract disorder—Doxorubicin—lung cancer	7.06e-06	0.000219	CcSEcCtD
Etoposide—Dysgeusia—Methotrexate—lung cancer	7.03e-06	0.000218	CcSEcCtD
Etoposide—Gastrointestinal disorder—Docetaxel—lung cancer	7.02e-06	0.000218	CcSEcCtD
Etoposide—Fatigue—Docetaxel—lung cancer	7.01e-06	0.000217	CcSEcCtD
Etoposide—Urethral disorder—Doxorubicin—lung cancer	7e-06	0.000217	CcSEcCtD
Etoposide—Nausea—Irinotecan—lung cancer	6.99e-06	0.000217	CcSEcCtD
Etoposide—Pain—Docetaxel—lung cancer	6.95e-06	0.000216	CcSEcCtD
Etoposide—Constipation—Docetaxel—lung cancer	6.95e-06	0.000216	CcSEcCtD
Etoposide—Back pain—Methotrexate—lung cancer	6.95e-06	0.000215	CcSEcCtD
Etoposide—Asthenia—Paclitaxel—lung cancer	6.88e-06	0.000213	CcSEcCtD
Etoposide—Nausea—Gemcitabine—lung cancer	6.81e-06	0.000211	CcSEcCtD
Etoposide—Vomiting—Cisplatin—lung cancer	6.79e-06	0.00021	CcSEcCtD
Etoposide—Pruritus—Paclitaxel—lung cancer	6.79e-06	0.00021	CcSEcCtD
Etoposide—Erythema multiforme—Doxorubicin—lung cancer	6.75e-06	0.000209	CcSEcCtD
Etoposide—Rash—Cisplatin—lung cancer	6.73e-06	0.000209	CcSEcCtD
Etoposide—Dermatitis—Cisplatin—lung cancer	6.73e-06	0.000209	CcSEcCtD
Etoposide—Feeling abnormal—Docetaxel—lung cancer	6.7e-06	0.000208	CcSEcCtD
Etoposide—Eye disorder—Doxorubicin—lung cancer	6.68e-06	0.000207	CcSEcCtD
Etoposide—Ill-defined disorder—Methotrexate—lung cancer	6.66e-06	0.000207	CcSEcCtD
Etoposide—Gastrointestinal pain—Docetaxel—lung cancer	6.65e-06	0.000206	CcSEcCtD
Etoposide—Anaemia—Methotrexate—lung cancer	6.64e-06	0.000206	CcSEcCtD
Etoposide—Cardiac disorder—Doxorubicin—lung cancer	6.63e-06	0.000205	CcSEcCtD
Etoposide—Flushing—Doxorubicin—lung cancer	6.63e-06	0.000205	CcSEcCtD
Etoposide—Diarrhoea—Paclitaxel—lung cancer	6.56e-06	0.000203	CcSEcCtD
Etoposide—Angiopathy—Doxorubicin—lung cancer	6.48e-06	0.000201	CcSEcCtD
Etoposide—Malaise—Methotrexate—lung cancer	6.48e-06	0.000201	CcSEcCtD
Etoposide—Immune system disorder—Doxorubicin—lung cancer	6.45e-06	0.0002	CcSEcCtD
Etoposide—Vertigo—Methotrexate—lung cancer	6.45e-06	0.0002	CcSEcCtD
Etoposide—Mediastinal disorder—Doxorubicin—lung cancer	6.44e-06	0.0002	CcSEcCtD
Etoposide—Body temperature increased—Docetaxel—lung cancer	6.43e-06	0.000199	CcSEcCtD
Etoposide—Abdominal pain—Docetaxel—lung cancer	6.43e-06	0.000199	CcSEcCtD
Etoposide—Leukopenia—Methotrexate—lung cancer	6.43e-06	0.000199	CcSEcCtD
Etoposide—Chills—Doxorubicin—lung cancer	6.41e-06	0.000199	CcSEcCtD
Etoposide—Dizziness—Paclitaxel—lung cancer	6.34e-06	0.000197	CcSEcCtD
Etoposide—Nausea—Cisplatin—lung cancer	6.34e-06	0.000197	CcSEcCtD
Etoposide—Alopecia—Doxorubicin—lung cancer	6.31e-06	0.000196	CcSEcCtD
Etoposide—Cough—Methotrexate—lung cancer	6.27e-06	0.000194	CcSEcCtD
Etoposide—Convulsion—Methotrexate—lung cancer	6.22e-06	0.000193	CcSEcCtD
Etoposide—Chest pain—Methotrexate—lung cancer	6.11e-06	0.00019	CcSEcCtD
Etoposide—Vomiting—Paclitaxel—lung cancer	6.1e-06	0.000189	CcSEcCtD
Etoposide—TOP2A—Daunorubicin—Doxorubicin—lung cancer	6.1e-06	0.00947	CbGdCrCtD
Etoposide—TOP2A—Epirubicin—Doxorubicin—lung cancer	6.1e-06	0.00947	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Doxorubicin—lung cancer	6.1e-06	0.00947	CbGdCrCtD
Etoposide—Dysgeusia—Doxorubicin—lung cancer	6.09e-06	0.000189	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.07e-06	0.000188	CcSEcCtD
Etoposide—Rash—Paclitaxel—lung cancer	6.05e-06	0.000187	CcSEcCtD
Etoposide—Dermatitis—Paclitaxel—lung cancer	6.04e-06	0.000187	CcSEcCtD
Etoposide—Discomfort—Methotrexate—lung cancer	6.04e-06	0.000187	CcSEcCtD
Etoposide—Back pain—Doxorubicin—lung cancer	6.02e-06	0.000186	CcSEcCtD
Etoposide—Headache—Paclitaxel—lung cancer	6.01e-06	0.000186	CcSEcCtD
Etoposide—Hypersensitivity—Docetaxel—lung cancer	5.99e-06	0.000186	CcSEcCtD
Etoposide—Muscle spasms—Doxorubicin—lung cancer	5.98e-06	0.000185	CcSEcCtD
Etoposide—Confusional state—Methotrexate—lung cancer	5.91e-06	0.000183	CcSEcCtD
Etoposide—Anaphylactic shock—Methotrexate—lung cancer	5.86e-06	0.000182	CcSEcCtD
Etoposide—Asthenia—Docetaxel—lung cancer	5.83e-06	0.000181	CcSEcCtD
Etoposide—Infection—Methotrexate—lung cancer	5.82e-06	0.00018	CcSEcCtD
Etoposide—Ill-defined disorder—Doxorubicin—lung cancer	5.77e-06	0.000179	CcSEcCtD
Etoposide—Pruritus—Docetaxel—lung cancer	5.75e-06	0.000178	CcSEcCtD
Etoposide—Anaemia—Doxorubicin—lung cancer	5.75e-06	0.000178	CcSEcCtD
Etoposide—Thrombocytopenia—Methotrexate—lung cancer	5.74e-06	0.000178	CcSEcCtD
Etoposide—Nausea—Paclitaxel—lung cancer	5.7e-06	0.000177	CcSEcCtD
Etoposide—Skin disorder—Methotrexate—lung cancer	5.69e-06	0.000176	CcSEcCtD
Etoposide—Hyperhidrosis—Methotrexate—lung cancer	5.67e-06	0.000176	CcSEcCtD
Etoposide—Malaise—Doxorubicin—lung cancer	5.61e-06	0.000174	CcSEcCtD
Etoposide—Vertigo—Doxorubicin—lung cancer	5.59e-06	0.000173	CcSEcCtD
Etoposide—Anorexia—Methotrexate—lung cancer	5.59e-06	0.000173	CcSEcCtD
Etoposide—Leukopenia—Doxorubicin—lung cancer	5.57e-06	0.000173	CcSEcCtD
Etoposide—Diarrhoea—Docetaxel—lung cancer	5.56e-06	0.000172	CcSEcCtD
Etoposide—Hypotension—Methotrexate—lung cancer	5.48e-06	0.00017	CcSEcCtD
Etoposide—Loss of consciousness—Doxorubicin—lung cancer	5.47e-06	0.000169	CcSEcCtD
Etoposide—Cough—Doxorubicin—lung cancer	5.43e-06	0.000168	CcSEcCtD
Etoposide—Convulsion—Doxorubicin—lung cancer	5.39e-06	0.000167	CcSEcCtD
Etoposide—Dizziness—Docetaxel—lung cancer	5.38e-06	0.000167	CcSEcCtD
Etoposide—Hypertension—Doxorubicin—lung cancer	5.37e-06	0.000166	CcSEcCtD
Etoposide—Chest pain—Doxorubicin—lung cancer	5.29e-06	0.000164	CcSEcCtD
Etoposide—Paraesthesia—Methotrexate—lung cancer	5.26e-06	0.000163	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.26e-06	0.000163	CcSEcCtD
Etoposide—Discomfort—Doxorubicin—lung cancer	5.23e-06	0.000162	CcSEcCtD
Etoposide—Dyspnoea—Methotrexate—lung cancer	5.23e-06	0.000162	CcSEcCtD
Etoposide—Somnolence—Methotrexate—lung cancer	5.21e-06	0.000161	CcSEcCtD
Etoposide—Vomiting—Docetaxel—lung cancer	5.17e-06	0.00016	CcSEcCtD
Etoposide—Rash—Docetaxel—lung cancer	5.13e-06	0.000159	CcSEcCtD
Etoposide—Dermatitis—Docetaxel—lung cancer	5.12e-06	0.000159	CcSEcCtD
Etoposide—Confusional state—Doxorubicin—lung cancer	5.12e-06	0.000159	CcSEcCtD
Etoposide—TOP2A—Azacitidine—Gemcitabine—lung cancer	5.1e-06	0.00791	CbGdCrCtD
Etoposide—Decreased appetite—Methotrexate—lung cancer	5.1e-06	0.000158	CcSEcCtD
Etoposide—Headache—Docetaxel—lung cancer	5.09e-06	0.000158	CcSEcCtD
Etoposide—Anaphylactic shock—Doxorubicin—lung cancer	5.08e-06	0.000157	CcSEcCtD
Etoposide—Gastrointestinal disorder—Methotrexate—lung cancer	5.06e-06	0.000157	CcSEcCtD
Etoposide—Fatigue—Methotrexate—lung cancer	5.05e-06	0.000157	CcSEcCtD
Etoposide—Infection—Doxorubicin—lung cancer	5.04e-06	0.000156	CcSEcCtD
Etoposide—Pain—Methotrexate—lung cancer	5.01e-06	0.000155	CcSEcCtD
Etoposide—Thrombocytopenia—Doxorubicin—lung cancer	4.97e-06	0.000154	CcSEcCtD
Etoposide—Tachycardia—Doxorubicin—lung cancer	4.95e-06	0.000154	CcSEcCtD
Etoposide—Skin disorder—Doxorubicin—lung cancer	4.93e-06	0.000153	CcSEcCtD
Etoposide—Hyperhidrosis—Doxorubicin—lung cancer	4.91e-06	0.000152	CcSEcCtD
Etoposide—Anorexia—Doxorubicin—lung cancer	4.84e-06	0.00015	CcSEcCtD
Etoposide—Nausea—Docetaxel—lung cancer	4.83e-06	0.00015	CcSEcCtD
Etoposide—Feeling abnormal—Methotrexate—lung cancer	4.83e-06	0.00015	CcSEcCtD
Etoposide—Gastrointestinal pain—Methotrexate—lung cancer	4.79e-06	0.000149	CcSEcCtD
Etoposide—Hypotension—Doxorubicin—lung cancer	4.74e-06	0.000147	CcSEcCtD
Etoposide—Urticaria—Methotrexate—lung cancer	4.66e-06	0.000144	CcSEcCtD
Etoposide—Abdominal pain—Methotrexate—lung cancer	4.63e-06	0.000144	CcSEcCtD
Etoposide—Body temperature increased—Methotrexate—lung cancer	4.63e-06	0.000144	CcSEcCtD
Etoposide—Paraesthesia—Doxorubicin—lung cancer	4.56e-06	0.000141	CcSEcCtD
Etoposide—Dyspnoea—Doxorubicin—lung cancer	4.52e-06	0.00014	CcSEcCtD
Etoposide—Somnolence—Doxorubicin—lung cancer	4.51e-06	0.00014	CcSEcCtD
Etoposide—Decreased appetite—Doxorubicin—lung cancer	4.41e-06	0.000137	CcSEcCtD
Etoposide—Gastrointestinal disorder—Doxorubicin—lung cancer	4.38e-06	0.000136	CcSEcCtD
Etoposide—Fatigue—Doxorubicin—lung cancer	4.38e-06	0.000136	CcSEcCtD
Etoposide—Constipation—Doxorubicin—lung cancer	4.34e-06	0.000135	CcSEcCtD
Etoposide—Pain—Doxorubicin—lung cancer	4.34e-06	0.000135	CcSEcCtD
Etoposide—Hypersensitivity—Methotrexate—lung cancer	4.32e-06	0.000134	CcSEcCtD
Etoposide—Asthenia—Methotrexate—lung cancer	4.21e-06	0.00013	CcSEcCtD
Etoposide—Feeling abnormal—Doxorubicin—lung cancer	4.18e-06	0.00013	CcSEcCtD
Etoposide—Gastrointestinal pain—Doxorubicin—lung cancer	4.15e-06	0.000129	CcSEcCtD
Etoposide—Pruritus—Methotrexate—lung cancer	4.15e-06	0.000129	CcSEcCtD
Etoposide—Urticaria—Doxorubicin—lung cancer	4.03e-06	0.000125	CcSEcCtD
Etoposide—Abdominal pain—Doxorubicin—lung cancer	4.01e-06	0.000124	CcSEcCtD
Etoposide—Body temperature increased—Doxorubicin—lung cancer	4.01e-06	0.000124	CcSEcCtD
Etoposide—Diarrhoea—Methotrexate—lung cancer	4.01e-06	0.000124	CcSEcCtD
Etoposide—Dizziness—Methotrexate—lung cancer	3.88e-06	0.00012	CcSEcCtD
Etoposide—Hypersensitivity—Doxorubicin—lung cancer	3.74e-06	0.000116	CcSEcCtD
Etoposide—Vomiting—Methotrexate—lung cancer	3.73e-06	0.000116	CcSEcCtD
Etoposide—Rash—Methotrexate—lung cancer	3.7e-06	0.000115	CcSEcCtD
Etoposide—Dermatitis—Methotrexate—lung cancer	3.69e-06	0.000114	CcSEcCtD
Etoposide—Headache—Methotrexate—lung cancer	3.67e-06	0.000114	CcSEcCtD
Etoposide—Asthenia—Doxorubicin—lung cancer	3.64e-06	0.000113	CcSEcCtD
Etoposide—Pruritus—Doxorubicin—lung cancer	3.59e-06	0.000111	CcSEcCtD
Etoposide—Nausea—Methotrexate—lung cancer	3.48e-06	0.000108	CcSEcCtD
Etoposide—Diarrhoea—Doxorubicin—lung cancer	3.47e-06	0.000108	CcSEcCtD
Etoposide—Dizziness—Doxorubicin—lung cancer	3.36e-06	0.000104	CcSEcCtD
Etoposide—Vomiting—Doxorubicin—lung cancer	3.23e-06	0.0001	CcSEcCtD
Etoposide—Rash—Doxorubicin—lung cancer	3.2e-06	9.92e-05	CcSEcCtD
Etoposide—Dermatitis—Doxorubicin—lung cancer	3.2e-06	9.91e-05	CcSEcCtD
Etoposide—Headache—Doxorubicin—lung cancer	3.18e-06	9.85e-05	CcSEcCtD
Etoposide—Nausea—Doxorubicin—lung cancer	3.01e-06	9.34e-05	CcSEcCtD
Etoposide—CYP3A4—Metabolism—GSTA4—lung cancer	5.63e-07	2.92e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—TYMS—lung cancer	5.63e-07	2.91e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP1A1—lung cancer	5.61e-07	2.91e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	5.59e-07	2.89e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTM1—lung cancer	5.57e-07	2.89e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ERCC2—lung cancer	5.57e-07	2.88e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTM1—lung cancer	5.56e-07	2.88e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP2E1—lung cancer	5.54e-07	2.87e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CG—lung cancer	5.54e-07	2.87e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTEN—lung cancer	5.54e-07	2.87e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ADCY1—lung cancer	5.53e-07	2.86e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ABCG2—lung cancer	5.53e-07	2.86e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTA2—lung cancer	5.49e-07	2.84e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—POMC—lung cancer	5.49e-07	2.84e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NQO1—lung cancer	5.48e-07	2.84e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—HPGDS—lung cancer	5.42e-07	2.81e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ENO2—lung cancer	5.42e-07	2.81e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PPP2R1B—lung cancer	5.39e-07	2.79e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CREBBP—lung cancer	5.35e-07	2.77e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.32e-07	2.75e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.32e-07	2.75e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTA1—lung cancer	5.3e-07	2.74e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP1A1—lung cancer	5.28e-07	2.74e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—EP300—lung cancer	5.28e-07	2.73e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP1A1—lung cancer	5.27e-07	2.73e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—POMC—lung cancer	5.27e-07	2.73e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTT1—lung cancer	5.26e-07	2.72e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—KIT—lung cancer	5.25e-07	2.72e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—APC—lung cancer	5.25e-07	2.72e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTP1—lung cancer	5.24e-07	2.71e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ERCC2—lung cancer	5.24e-07	2.71e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCC3—lung cancer	5.24e-07	2.71e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ERCC2—lung cancer	5.23e-07	2.71e-05	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	5.22e-07	2.7e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CB—lung cancer	5.21e-07	2.7e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GCLC—lung cancer	5.2e-07	2.69e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP2A6—lung cancer	5.2e-07	2.69e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1A—lung cancer	5.19e-07	2.69e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGF—lung cancer	5.19e-07	2.69e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.18e-07	2.68e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTEN—lung cancer	5.18e-07	2.68e-05	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—lung cancer	5.17e-07	2.67e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTGS2—lung cancer	5.16e-07	2.67e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CREBBP—lung cancer	5.14e-07	2.66e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CAT—lung cancer	5.1e-07	2.64e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.07e-07	2.63e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKR1C1—lung cancer	5.07e-07	2.63e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CD—lung cancer	5.07e-07	2.62e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CB—lung cancer	5.02e-07	2.6e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ALB—lung cancer	5e-07	2.59e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTGS2—lung cancer	4.97e-07	2.58e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ABCB1—lung cancer	4.96e-07	2.57e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—EP300—lung cancer	4.94e-07	2.56e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—STK11—lung cancer	4.94e-07	2.56e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—BRAF—lung cancer	4.94e-07	2.56e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ENO1—lung cancer	4.93e-07	2.55e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—UGT1A1—lung cancer	4.92e-07	2.55e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.91e-07	2.54e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6R—lung cancer	4.88e-07	2.52e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—TYMS—lung cancer	4.87e-07	2.52e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CD—lung cancer	4.87e-07	2.52e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CREBBP—lung cancer	4.87e-07	2.52e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.85e-07	2.51e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTM1—lung cancer	4.82e-07	2.49e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—APOA1—lung cancer	4.82e-07	2.49e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ALB—lung cancer	4.81e-07	2.49e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—SRC—lung cancer	4.8e-07	2.49e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GNG11—lung cancer	4.75e-07	2.46e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAP2K1—lung cancer	4.65e-07	2.41e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—STAT3—lung cancer	4.63e-07	2.4e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—NRAS—lung cancer	4.62e-07	2.39e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CD—lung cancer	4.62e-07	2.39e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.61e-07	2.39e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTP1—lung cancer	4.57e-07	2.37e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP1A1—lung cancer	4.57e-07	2.36e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—APOA1—lung cancer	4.53e-07	2.35e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ERCC2—lung cancer	4.53e-07	2.35e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—APOA1—lung cancer	4.52e-07	2.34e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALDOA—lung cancer	4.52e-07	2.34e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTEN—lung cancer	4.5e-07	2.33e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CAT—lung cancer	4.45e-07	2.3e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAPK3—lung cancer	4.43e-07	2.29e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP2E1—lung cancer	4.42e-07	2.29e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CB—lung cancer	4.42e-07	2.29e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CG—lung cancer	4.4e-07	2.28e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NCOA3—lung cancer	4.39e-07	2.27e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTGS2—lung cancer	4.38e-07	2.27e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NQO1—lung cancer	4.37e-07	2.26e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTEN—lung cancer	4.34e-07	2.25e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—lung cancer	4.31e-07	2.23e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—EP300—lung cancer	4.29e-07	2.22e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.28e-07	2.22e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ADCY1—lung cancer	4.27e-07	2.21e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCG2—lung cancer	4.27e-07	2.21e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—TYMS—lung cancer	4.25e-07	2.2e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CB—lung cancer	4.24e-07	2.2e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.24e-07	2.2e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—EGFR—lung cancer	4.21e-07	2.18e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTGS2—lung cancer	4.21e-07	2.18e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTM1—lung cancer	4.2e-07	2.17e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HPGDS—lung cancer	4.19e-07	2.17e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ENO2—lung cancer	4.19e-07	2.17e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—POMC—lung cancer	4.19e-07	2.17e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.16e-07	2.15e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CG—lung cancer	4.14e-07	2.14e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—EP300—lung cancer	4.14e-07	2.14e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MDM2—lung cancer	4.14e-07	2.14e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CG—lung cancer	4.13e-07	2.14e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—RAF1—lung cancer	4.12e-07	2.13e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CREBBP—lung cancer	4.08e-07	2.11e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—ERBB2—lung cancer	4.08e-07	2.11e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTT1—lung cancer	4.06e-07	2.1e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MTOR—lung cancer	4.02e-07	2.08e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CB—lung cancer	4.02e-07	2.08e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CD4—lung cancer	4.02e-07	2.08e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP2A6—lung cancer	4.01e-07	2.08e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GCLC—lung cancer	4.01e-07	2.08e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP1A1—lung cancer	3.98e-07	2.06e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—KRAS—lung cancer	3.98e-07	2.06e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ERCC2—lung cancer	3.95e-07	2.04e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—STK11—lung cancer	3.94e-07	2.04e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—POMC—lung cancer	3.94e-07	2.04e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—POMC—lung cancer	3.93e-07	2.04e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—APOA1—lung cancer	3.92e-07	2.03e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CA—lung cancer	3.91e-07	2.02e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CD—lung cancer	3.87e-07	2e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CREBBP—lung cancer	3.84e-07	1.99e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CREBBP—lung cancer	3.83e-07	1.98e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTEN—lung cancer	3.82e-07	1.98e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ALB—lung cancer	3.82e-07	1.98e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ENO1—lung cancer	3.81e-07	1.97e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.75e-07	1.94e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.7e-07	1.92e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTEN—lung cancer	3.67e-07	1.9e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CA—lung cancer	3.65e-07	1.89e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTP1—lung cancer	3.65e-07	1.89e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—EP300—lung cancer	3.64e-07	1.88e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CD—lung cancer	3.64e-07	1.88e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CD—lung cancer	3.63e-07	1.88e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ALB—lung cancer	3.59e-07	1.86e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ALB—lung cancer	3.59e-07	1.86e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CG—lung cancer	3.58e-07	1.85e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CAT—lung cancer	3.55e-07	1.84e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.53e-07	1.83e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—EP300—lung cancer	3.5e-07	1.81e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1A—lung cancer	3.48e-07	1.8e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PTEN—lung cancer	3.48e-07	1.8e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ABCB1—lung cancer	3.45e-07	1.79e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—APOA1—lung cancer	3.41e-07	1.77e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP2E1—lung cancer	3.41e-07	1.77e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—POMC—lung cancer	3.41e-07	1.76e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—TYMS—lung cancer	3.39e-07	1.76e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—HRAS—lung cancer	3.38e-07	1.75e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NQO1—lung cancer	3.37e-07	1.75e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CB—lung cancer	3.37e-07	1.74e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTM1—lung cancer	3.35e-07	1.73e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CREBBP—lung cancer	3.32e-07	1.72e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EP300—lung cancer	3.32e-07	1.72e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—IL6—lung cancer	3.24e-07	1.68e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—SRC—lung cancer	3.22e-07	1.67e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—lung cancer	3.19e-07	1.65e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP1A1—lung cancer	3.18e-07	1.64e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CA—lung cancer	3.17e-07	1.64e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CB—lung cancer	3.17e-07	1.64e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CB—lung cancer	3.17e-07	1.64e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ERCC2—lung cancer	3.15e-07	1.63e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CD—lung cancer	3.15e-07	1.63e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS2—lung cancer	3.14e-07	1.63e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS2—lung cancer	3.14e-07	1.62e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CG—lung cancer	3.12e-07	1.61e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—STAT3—lung cancer	3.11e-07	1.61e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ALB—lung cancer	3.11e-07	1.61e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NRAS—lung cancer	3.1e-07	1.61e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CA—lung cancer	3.06e-07	1.58e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—STK11—lung cancer	3.04e-07	1.57e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—lung cancer	2.99e-07	1.55e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAPK3—lung cancer	2.97e-07	1.54e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—POMC—lung cancer	2.97e-07	1.54e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PTEN—lung cancer	2.91e-07	1.51e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CREBBP—lung cancer	2.89e-07	1.5e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—lung cancer	2.89e-07	1.5e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGFR—lung cancer	2.83e-07	1.46e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTP1—lung cancer	2.81e-07	1.46e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—EP300—lung cancer	2.78e-07	1.44e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CB—lung cancer	2.74e-07	1.42e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTEN—lung cancer	2.74e-07	1.42e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CD—lung cancer	2.74e-07	1.42e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CAT—lung cancer	2.74e-07	1.42e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTEN—lung cancer	2.74e-07	1.42e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—APOA1—lung cancer	2.73e-07	1.41e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS2—lung cancer	2.72e-07	1.41e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ALB—lung cancer	2.71e-07	1.4e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CA—lung cancer	2.69e-07	1.39e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—KRAS—lung cancer	2.67e-07	1.38e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCB1—lung cancer	2.66e-07	1.38e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TYMS—lung cancer	2.62e-07	1.35e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—EP300—lung cancer	2.61e-07	1.35e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.61e-07	1.35e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—EP300—lung cancer	2.61e-07	1.35e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—lung cancer	2.59e-07	1.34e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CA—lung cancer	2.59e-07	1.34e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTM1—lung cancer	2.59e-07	1.34e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—lung cancer	2.5e-07	1.29e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CG—lung cancer	2.49e-07	1.29e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CA—lung cancer	2.45e-07	1.27e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP1A1—lung cancer	2.45e-07	1.27e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ERCC2—lung cancer	2.43e-07	1.26e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CB—lung cancer	2.39e-07	1.24e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTEN—lung cancer	2.37e-07	1.23e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—POMC—lung cancer	2.37e-07	1.23e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS2—lung cancer	2.37e-07	1.23e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CREBBP—lung cancer	2.31e-07	1.19e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HRAS—lung cancer	2.27e-07	1.17e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—EP300—lung cancer	2.26e-07	1.17e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—lung cancer	2.2e-07	1.14e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CD—lung cancer	2.19e-07	1.13e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6—lung cancer	2.17e-07	1.12e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALB—lung cancer	2.16e-07	1.12e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—lung cancer	2.11e-07	1.09e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—APOA1—lung cancer	2.1e-07	1.09e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTEN—lung cancer	2.06e-07	1.07e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CA—lung cancer	2.05e-07	1.06e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—lung cancer	2e-07	1.04e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—EP300—lung cancer	1.97e-07	1.02e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CA—lung cancer	1.93e-07	1e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CA—lung cancer	1.93e-07	9.99e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CG—lung cancer	1.92e-07	9.94e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CB—lung cancer	1.91e-07	9.87e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS2—lung cancer	1.89e-07	9.78e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—POMC—lung cancer	1.83e-07	9.46e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CREBBP—lung cancer	1.78e-07	9.22e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CD—lung cancer	1.69e-07	8.74e-06	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—lung cancer	1.68e-07	8.69e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CA—lung cancer	1.67e-07	8.65e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALB—lung cancer	1.67e-07	8.63e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTEN—lung cancer	1.65e-07	8.53e-06	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—lung cancer	1.58e-07	8.18e-06	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—lung cancer	1.58e-07	8.16e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—EP300—lung cancer	1.57e-07	8.13e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CB—lung cancer	1.47e-07	7.62e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS2—lung cancer	1.46e-07	7.55e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CA—lung cancer	1.46e-07	7.54e-06	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—lung cancer	1.37e-07	7.07e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTEN—lung cancer	1.27e-07	6.58e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—EP300—lung cancer	1.21e-07	6.28e-06	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—lung cancer	1.19e-07	6.16e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CA—lung cancer	1.16e-07	6.02e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—lung cancer	9.5e-08	4.92e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CA—lung cancer	8.97e-08	4.64e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—lung cancer	7.33e-08	3.79e-06	CbGpPWpGaD
